April 2009 - Volume 29 - Issue 2
pp: 105-199
Subscribe to eTOC


Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls

Ahn, Yong Min; Lee, Kyu Young; Kim, Chul-Eung; More

Journal of Clinical Psychopharmacology . 29(2):117-123, April 2009.

Decreased Activation Along the Dorsal Visual Pathway After a 3-Month Treatment With Galantamine in Mild Alzheimer Disease: A Functional Magnetic Resonance Imaging Study

Bokde, Arun L.W.; Karmann, Michaela; Teipel, Stefan J.; More

Journal of Clinical Psychopharmacology . 29(2):147-156, April 2009.



Clonidine Improves Hyperarousal in Borderline Personality Disorder With or Without Comorbid Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Ziegenhorn, Andreas A.; Roepke, Stefan; Schommer, Nicole C.; More

Journal of Clinical Psychopharmacology . 29(2):170-173, April 2009.



Comparing the Effects of High-Dose Vitamin E With Those of Placebo on Insulin Resistance in Patients With Schizophrenia Treated With Olanzapine

Salmasi, Fiona Baroyant; Jazayeri, Maryam; Ghaeli, Padideh; More

Journal of Clinical Psychopharmacology . 29(2):182-183, April 2009.

1 2 3 4 5